• Citer

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.

par Declercq, Jozefien;Van Damme, Karel KFA;De Leeuw, Elisabeth;Maes, Bastiaan;Bosteels, Cedric;Tavernier, Simon J;De Buyser, Stefanie;Colman, Roos;Hites, Maya ;Verschelden, Gil ;Fivez, Tom;Moerman, Filip;Demedts, Ingel K;Dauby, Nicolas ;De Schryver, Nicolas;Govaerts, Elke;Vandecasteele, Stefaan Johan;Van Laethem, Johan;Anguille, Sébastien;van der Hilst, Jeroen;Misset, Benoit;Slabbynck, Hans;Wittebole, Xavier;Liénart, Fabienne ;Legrand, Catherine;Buyse, Marc;Stevens, Albert Dieter;Bauters, Fre;Seys, Leen LJM;Aegerter, Helena;Smole, Ursula;Bosteels, Victor;Hoste, Levi;Naesens, Leslie;Haerynck, Filomeen;Vandekerckhove, Linos;Depuydt, Pieter;van Braeckel, Eva;Rottey, Sylvie;Peene, Isabelle;Van Der Straeten, Catherine;Hulstaert, Frank;Lambrecht, Bart N
Référence The Lancet Respiratory Medicine, 9, 12, page (1427-1438)
Publication Publié, 2021

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.
Auteur:	Declercq, Jozefien; Van Damme, Karel KFA; De Leeuw, Elisabeth; Maes, Bastiaan; Bosteels, Cedric; Tavernier, Simon J; De Buyser, Stefanie; Colman, Roos; Hites, Maya; Verschelden, Gil; Fivez, Tom; Moerman, Filip; Demedts, Ingel K; Dauby, Nicolas; De Schryver, Nicolas; Govaerts, Elke; Vandecasteele, Stefaan Johan; Van Laethem, Johan; Anguille, Sébastien; van der Hilst, Jeroen; Misset, Benoit; Slabbynck, Hans; Wittebole, Xavier; Liénart, Fabienne; Legrand, Catherine; Buyse, Marc; Stevens, Albert Dieter; Bauters, Fre; Seys, Leen LJM; Aegerter, Helena; Smole, Ursula; Bosteels, Victor; Hoste, Levi; Naesens, Leslie; Haerynck, Filomeen; Vandekerckhove, Linos; Depuydt, Pieter; van Braeckel, Eva; Rottey, Sylvie; Peene, Isabelle; Van Der Straeten, Catherine; Hulstaert, Frank; Lambrecht, Bart N
Informations sur la publication:	The Lancet Respiratory Medicine, 9, 12, page (1427-1438)
Statut de publication:	Publié, 2021
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Aged
	Antibodies, Monoclonal -- therapeutic use
	Antibodies, Monoclonal, Humanized -- therapeutic use
	Belgium
	COVID-19 -- drug therapy
	Cytokine Release Syndrome -- drug therapy -- virology
	Female
	Ferritins
	Humans
	Hypoxia
	Interleukin-1 -- antagonists & inhibitors
	Interleukin-6 -- antagonists & inhibitors
	Male
	Middle Aged
	Oxygen
	Prospective Studies
	Respiratory Insufficiency -- drug therapy -- virology
	SARS-CoV-2
	Treatment Outcome
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:2213-2600
	info:doi/10.1016/S2213-2600(21)00377-5
	info:pii/S2213-2600(21)00377-5
	info:scp/85118234494
	info:pmid/34756178
	PMC8555973